6/25/2012 10:05:00 AM
National Institutes of Health Awards $2.5M Grant for Nanotechnology-Enabled Research to Help Millions Suffering from ‘Dry Mouth’
Joint initiative between CNSE Nanobioscience Constellation and UAlbany Department of Biological Sciences to lay the groundwork for engineering of artificial salivary glands
| || |
|UAlbany Assistant Professor of Biological Sciences |
Dr. Melinda Larsen
|CNSE Professor and Nanobioscience Constellation Head |
Dr. James Castracane
Albany, NY – In a project that could provide welcome relief for millions of people who suffer from the effects of “dry mouth,” the National Institutes of Health (NIH) has awarded a $2.5 million grant to support joint research by faculty at the College of Nanoscale Science and Engineering (CNSE) of the University at Albany (UAlbany) and UAlbany’s Department of Biological Sciences.
Dr. Michael Liehr, CNSE Vice President for Research, said, “Further underscoring the leadership and commitment of Governor Andrew Cuomo to building a world-class, nanotechnology-driven innovation economy in New York, this funding from the National Institutes of Health leverages the NanoCollege’s growing expertise in nanobioscience and nanomedicine with the capability in basic cell biology research on the main campus of the University at Albany. I congratulate Dr. Larsen and Dr. Castracane on the receipt of this funding, and look forward to the advances made through their collaborative efforts, which offer tremendous potential to improve the quality of life for millions of people.”
“The potential medical significance of the research funded by this award underscores how innovative scientists at UAlbany are delivering on the promise of its Life Sciences and Nanoscale Sciences initiatives,” said Dr. James Dias, UAlbany Vice President for Research. “Attracting and incubating outstanding scientists like Dr. Larsen is a big payoff not only for UAlbany, but for biomedical science worldwide. Our CNSE colleagues like Dr. Castracane bring material science technological expertise. This diversifies and enriches experimental approaches enabling investigators in the life sciences ecosystem to reach, sometimes beyond their grasp of the underpinnings of new technologies that will be tomorrow’s cures.”
The innovative research will target improved treatment of xerostomia, or “dry mouth,” which results from a lack of saliva. Adequate treatments are not currently available for sufferers, who experience a variety of conditions, from oral and dental infections and loss of taste to difficulties with swallowing, digesting, and speaking. The condition can be caused by an autoimmune disease, such as Sjogren’s Syndrome, which leads to lack of saliva production by the salivary glands.
Through the NIH funding, lead investigators Dr. Melinda Larsen, UAlbany Assistant Professor of Biological Sciences, and Dr. James Castracane, Professor and Head of CNSE’s Nanobioscience Constellation, will work jointly on research that uses nanofibers to develop bioengineered artificial scaffolds. Those scaffolds would then be deployed to promote the growth of salivary gland cells, with a goal of enabling the future engineering of functional salivary glands.
Dr. Larsen said, “This research project allows my lab to apply our expertise in basic salivary gland biology to an important clinical problem. We are excited about our partnership with CNSE to understand how cells interact with nanomaterials that will enable us to design engineered tissues for future use in patients.”
Dr. Castracane said, “This critical funding from the National Institutes of Health will support groundbreaking research that has great promise to address a medical condition that causes serious health problems for so many people. I am delighted to work in partnership with Dr. Larsen on this innovative research, and excited with the opportunity to further showcase the state-of-the-art capabilities of CNSE’s pioneering Nanobioscience Constellation, as well as the benefits of those efforts.”
This novel approach involves a multi-step process, which includes developing a non-invasive, high-throughput micro-electro-mechanical system (MEMS) probe to sense salivary cell function in live cells that are grown on nanoscale-sized scaffold materials, something that was not previously possible. The investigators will design “smart” scaffolds that direct cell behavior to stimulate cell function. In addition to informing the future engineering of artificial salivary glands, the principles developed through this research will also be applied to treat diseases in other complex branching organs, and to improve the drug screening process.
Funded through NIH’s National Institute of Dental and Craniofacial Research, the grant covers research to be conducted in Albany over the next five years.
About CNSE. The UAlbany CNSE is the first college in the world dedicated to education, research, development and deployment in the emerging disciplines of nanoscience, nanoengineering, nanobioscience and nanoeconomics. With more than $14 billion in high-tech investments, CNSE represents the world’s most advanced university-driven research enterprise, offering students a one-of-a-kind academic experience and providing over 300 corporate partners with access to an unmatched ecosystem for leading-edge R&D and commercialization of nanoelectronics and nanotechnology innovations. CNSE’s footprint spans upstate New York, including its Albany NanoTech Complex, an 800,000-square-foot megaplex with the only fully-integrated, 300mm wafer, computer chip pilot prototyping and demonstration line within 85,000 square feet of Class 1 capable cleanrooms. More than 2,700 scientists, researchers, engineers, students and faculty work here, from companies including IBM, Intel, GlobalFoundries, SEMATECH, Samsung, TSMC, Toshiba, Applied Materials, Tokyo Electron, ASML and Novellus Systems. An expansion now underway, part of which will house the world’s first Global 450mm Consortium, will add nearly 500,000 square feet of next-generation infrastructure, an additional 50,000 square feet of Class 1 capable cleanrooms, and more than 1,000 scientists, researchers and engineers from CNSE and global corporations. In addition, CNSE’s Solar Energy Development Center in Halfmoon provides a prototyping and demonstration line for next-generation CIGS thin-film solar cells. CNSE’s Smart Systems Technology and Commercialization Center of Excellence (STC) in Rochester offers state-of-the-art capabilities for MEMS fabrication and packaging. CNSE also co-founded and manages operations at the Computer Chip Commercialization Center at SUNYIT in Utica and is a co-founder of the Nanotechnology Innovation and Commercialization Excelerator in Syracuse. For information, visit www.cnse.albany.edu.
About University at Albany
For more news, subscribe to UAlbany's RSS feed
, or follow the University on Facebook
Educationally and culturally, the University at Albany-SUNY puts "The World Within Reach" for its 18,000 students. An internationally recognized research university with 56 undergraduate majors and 115 graduate degree programs, The university is home to the state of the art Life Science Research Building that houses professors from the Departments of Biological Science, Chemistry, Physics and Computer Science who are engaged in cutting edge interdisciplinary research and is also the home of the recently launched RNA Institute. UAlbany is a leader among all New York State colleges and universities in such diverse fields as public policy, nanotechnology and criminal justice. With a curriculum enhanced by 300 study-abroad opportunities, UAlbany launches great careers. Visit UAlbany's extensive roster of faculty experts.
Contact: Steve Janack, Vice President for Marketing and Communications, CNSE
(518) 956-7322 | firstname.lastname@example.org
Cathy Herman, UAlbany VP Communications and Marketing